| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $3.86 ▲ +1.59% | Yesterday | $3.77 ▼ -0.67% | Tomorrow's AN2 Therapeutics Inc. Common Stock (ANTX) setup is anchored to $3.80 and targets $3.86 (+1.59%). The near-term read is upside; watch $3.91 / $3.69 because daily realized volatility is about 8.00%. |
Tomorrow's AN2 Therapeutics Inc. Common Stock (ANTX) setup is anchored to $3.80 and targets $3.86 (+1.59%). The near-term read is upside; watch $3.91 / $3.69 because daily realized volatility is about 8.00%. | ||||
| Week | $3.99 ▲ +4.95% | Last Week | $3.72 ▼ -2.08% | The 7-day AN2 Therapeutics Inc. Common Stock model moves from $3.72 to $3.99 (+4.95%). It gives upside momentum context for this stock, so breaks around $3.91 / $3.69 matter more than a single tick. |
The 7-day AN2 Therapeutics Inc. Common Stock model moves from $3.72 to $3.99 (+4.95%). It gives upside momentum context for this stock, so breaks around $3.91 / $3.69 matter more than a single tick. | ||||
| Month | $4.20 ▲ +10.54% | Last Month | $3.63 ▼ -4.43% | The 1-month AN2 Therapeutics Inc. Common Stock target is $4.20 (+10.54%), compared with the live reference near $3.80. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month AN2 Therapeutics Inc. Common Stock target is $4.20 (+10.54%), compared with the live reference near $3.80. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $4.52 ▲ +18.93% | Last Year | $3.50 ▼ -7.95% | The 1-year AN2 Therapeutics Inc. Common Stock scenario points to $4.52 (+18.93%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year AN2 Therapeutics Inc. Common Stock scenario points to $4.52 (+18.93%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $5.27 ▲ +38.57% | 5 Years Ago | $3.18 ▼ -16.20% | The 5-year AN2 Therapeutics Inc. Common Stock view is $5.27 (+38.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year AN2 Therapeutics Inc. Common Stock view is $5.27 (+38.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $3.80 | Mid |
| Daily Change | +4.97% | Above |
| Volatility Cap | 20.0% | Mid |
| Confidence | 68% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $3.80 | Daily Change | +4.97% |
| Market Cap | $136.58M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.